Requirement: pharmaceutical interventions for noise induced hearing loss acute exposure treatment (pinihl AET) action: award.
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH19C0054
- Awardee
-
The Washington University UEI L6NFUM28LQM5
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $8,690,236
Award facts
- Opportunity
-
- W81XWH18R0025 Solicitation number
- Pharmaceutical Interventions for Noise-Induced Hearing Loss--Acute Exposure Treatment (PINIHL-AET) Award Notice · Posted Jun 15, 2018
- Contract value 100% obligated
- $8,690,236.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- University City, MO 63130, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$827,373 | |
| Supplemental Agreement for work within scope | -$953,126 | |
| Supplemental Agreement for work within scope | -$2,805,290 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $2,805,290 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $3,830,028 | |
| Supplemental Agreement for work within scope | $301,428 | |
| Funding Only Action | $2,273,572 | |
| Supplemental Agreement for work within scope | $2,361,000 | |
| Original award | $1,704,708 |
Show all 11
About this award
This is a federal contract award from the Defense Health Agency to Washington University, a private research university in St. Louis, Missouri, for $8,690,236.44. The contract is to conduct research on the use of the drug zonisamide to prevent noise-induced hearing loss in surgical and military environments.
The research will be conducted at multiple sites, including Washington University School of Medicine, University of Akron, Gateway Biotechnology Inc., and University of Texas at Dallas. The contract does not have a set-aside designation. The key subcontractors include Gateway Biotechnology, a minority-owned small business, and the University of Texas at Dallas, a prominent public research university. This contract supports the Defense Health Agency's mission to provide medical research and development services.
Quick answers
Who was awarded contract W81XWH19C0054?
W81XWH19C0054 was awarded to The Washington University by Defense Health Agency (Department of Defense) on January 11, 2019.
How much is contract W81XWH19C0054 worth?
The government has obligated $8,690,236 on W81XWH19C0054.
Was contract W81XWH19C0054 competed?
The extent of competition for W81XWH19C0054 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award